These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 2646087
1. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs. Robinson MG, Griffin JW, Bowers J, Kogan FJ, Kogut DG, Lanza FL, Warner CW. Dig Dis Sci; 1989 Mar; 34(3):424-8. PubMed ID: 2646087 [Abstract] [Full Text] [Related]
2. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients. Bianchi Porro G, Lazzaroni M, Petrillo M. Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319 [Abstract] [Full Text] [Related]
3. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. Ehsanullah RS, Page MC, Tildesley G, Wood JR. BMJ; 1988 Oct 22; 297(6655):1017-21. PubMed ID: 3142593 [Abstract] [Full Text] [Related]
4. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs. Dajani EZ, Agrawal NM. Dig Dis; 1995 Jan 22; 13 Suppl 1():48-61. PubMed ID: 7697902 [Abstract] [Full Text] [Related]
5. Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury. Sartori S, Trevisani L, Nielsen I, Tassinari D, Panzini I, Abbasciano V. J Clin Oncol; 2000 Feb 22; 18(3):463-7. PubMed ID: 10653861 [Abstract] [Full Text] [Related]
6. Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen. Oddsson E, Gudjónsson H, Thjódleifsson B. Scand J Gastroenterol; 1992 Dec 22; 27(12):1045-8. PubMed ID: 1475621 [Abstract] [Full Text] [Related]
8. Nonsteroidal antiinflammatory drugs for cancer pain: comparison between misoprostol and ranitidine in prevention of upper gastrointestinal damage. Valentini M, Cannizzaro R, Poletti M, Bortolussi R, Fracasso A, Testa V, Sozzi M, Fornasarig M, Bortoluzzi F, Grazioli I. J Clin Oncol; 1995 Oct 22; 13(10):2637-42. PubMed ID: 7595718 [Abstract] [Full Text] [Related]
9. [Ranitidine in the treatment of non-steroidal anti-inflammatory agent-induced damage of the stomach and duodenal mucosa. Results of a randomized, placebo-controlled double-blind study in patients with rheumatic diseases]. Simon B, Beckers KH, Biewer W, Bouzo MH, Dammann HG, Gebest HJ, Müller P, Schütz E. Z Gastroenterol; 1988 Jun 22; 26(6):310-3. PubMed ID: 3061183 [Abstract] [Full Text] [Related]
10. Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients. Bianchi Porro G, Montrone F, Petrillo M, Caruso I, Ardizzone S. Scand J Gastroenterol; 1993 Oct 22; 28(10):875-8. PubMed ID: 8266016 [Abstract] [Full Text] [Related]
11. Effect of ranitidine on gastroduodenal mucosal damage in patients on long-term non-steroidal anti-inflammatory drugs. Swift GL, Heneghan M, Williams GT, Williams BD, O'Sullivan MM, Rhodes J. Digestion; 1989 Oct 22; 44(2):86-94. PubMed ID: 2693162 [Abstract] [Full Text] [Related]
12. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. Yeomans ND, Tulassay Z, Juhász L, Rácz I, Howard JM, van Rensburg CJ, Swannell AJ, Hawkey CJ. N Engl J Med; 1998 Mar 12; 338(11):719-26. PubMed ID: 9494148 [Abstract] [Full Text] [Related]
13. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study. Raskin JB, White RH, Jaszewski R, Korsten MA, Schubert TT, Fort JG. Am J Gastroenterol; 1996 Feb 12; 91(2):223-7. PubMed ID: 8607484 [Abstract] [Full Text] [Related]
14. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years. Goldstein JL, Aisenberg J, Lanza F, Schwartz H, Sands GH, Berger MF, Pan S. Clin Ther; 2006 Mar 12; 28(3):340-51. PubMed ID: 16750449 [Abstract] [Full Text] [Related]
15. [High-dose ranitidine protects stomach and duodenum completely against piroxicam. An endoscopic double-blind pilot study]. Müller P, Leucht U, Simon B. Z Gastroenterol; 1992 Dec 12; 30(12):851-3. PubMed ID: 1481550 [Abstract] [Full Text] [Related]
16. Ranitidine protects against gastroduodenal mucosal damage associated with chronic aspirin therapy. Berkowitz JM, Rogenes PR, Sharp JT, Warner CW. Arch Intern Med; 1987 Dec 12; 147(12):2137-9. PubMed ID: 3689065 [Abstract] [Full Text] [Related]
17. Approaches to healing and prophylaxis of nonsteroidal anti-inflammatory drug-associated ulcers. Yeomans ND. Am J Med; 2001 Jan 08; 110(1A):24S-28S. PubMed ID: 11165992 [Abstract] [Full Text] [Related]
18. [Misoprostol in the prevention of gastric erosions caused by nonsteroidal anti-inflammatory agents]. Delmas PD, Lambert R, Capron MH. Rev Rhum Ed Fr; 1994 Feb 08; 61(2):126-31. PubMed ID: 7920500 [Abstract] [Full Text] [Related]
19. Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs. Hawkey CJ, Naesdal J, Wilson I, Långström G, Swannell AJ, Peacock RA, Yeomans ND. Gut; 2002 Sep 08; 51(3):336-43. PubMed ID: 12171953 [Abstract] [Full Text] [Related]
20. Reduction of aspirin-induced gastroduodenal mucosal damage with ranitidine. Berkowitz JM, Adler SN, Sharp JT, Warner CW. J Clin Gastroenterol; 1986 Jun 08; 8(3 Pt 2):377-80. PubMed ID: 3531311 [Abstract] [Full Text] [Related] Page: [Next] [New Search]